Neurogene Inc.
NGNENasdaqCIK 1404644HealthcareFiscal year ends Dec 31
Reports and events: 240 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1120:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001404644-26-000059 |
| 2026-08-1111:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000056 |
| 2026-07-0200:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-26-000050 |
| 2026-06-2912:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-26-000046 |
| 2026-06-0811:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000044 |
| 2026-06-0420:41 ET | 8-K | 5.07 Shareholder vote results | 0001404644-26-000040 |
| 2026-05-1220:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000038 |
| 2026-05-1220:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001404644-26-000037 |
| 2026-04-2011:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000030 |
| 2026-04-1620:15 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001404644-26-000027 |
| 2026-03-2420:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001404644-26-000019 |
| 2026-03-2411:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000012 |
| 2026-02-2621:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000006 |
| 2026-01-1212:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000003 |
| 2025-11-1322:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000103 |
| 2025-11-1321:55 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001404644-25-000101 |
| 2025-11-1222:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000098 |
| 2025-11-0612:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000091 |
| 2025-10-0911:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000088 |
| 2025-08-1120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000082 |
| 2025-08-1120:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001404644-25-000081 |
| 2025-06-3020:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000070 |
| 2025-06-1220:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001404644-25-000053 |
| 2025-06-0911:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-25-000049 |
| 2025-05-0911:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000044 |
| 2025-05-0911:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001404644-25-000041 |
| 2025-04-2513:53 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001404644-25-000034 |
| 2025-04-1420:50 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-25-000029 |
| 2025-03-2420:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000014 |
| 2025-03-2420:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001404644-25-000012 |
| 2025-01-1312:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000004 |
| 2024-12-0222:27 ET | S-1 | Registration statement | 0001628280-24-049615 |
| 2024-11-2121:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001404644-24-000109 |
| 2024-11-1822:27 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001404644-24-000104 |
| 2024-11-1822:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000103 |
| 2024-11-1811:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000097 |
| 2024-11-1211:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000091 |
| 2024-11-0412:33 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000089 |
| 2024-08-0920:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001404644-24-000086 |
| 2024-08-0911:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000085 |
| 2024-08-0711:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000083 |
| 2024-06-2112:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000080 |
| 2024-06-1818:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000073 |
| 2024-06-1718:35 ET | 8-K | 5.07 Shareholder vote results | 0001404644-24-000066 |
| 2024-06-0311:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000059 |
| 2024-05-1020:14 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001404644-24-000057 |
| 2024-05-1011:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000054 |
| 2024-05-0710:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000049 |
| 2024-04-2618:33 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001404644-24-000043 |
| 2024-04-2521:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001404644-24-000041 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.